GEHC
Price
$60.76
Change
-$1.91 (-3.05%)
Updated
May 15 closing price
Capitalization
27.64B
Intraday BUY SELL Signals
PHG
Price
$25.23
Change
-$0.27 (-1.06%)
Updated
May 15 closing price
Capitalization
24.6B
73 days until earnings call
Intraday BUY SELL Signals
RYLPF
Price
$25.50
Change
-$1.43 (-5.31%)
Updated
May 14 closing price
Capitalization
25.66B
Intraday BUY SELL Signals
Interact to see
Advertisement

GEHC or PHG or RYLPF

Header iconGEHC vs PHG vs RYLPF Comparison
Open Charts GEHC vs PHG vs RYLPFBanner chart's image
GEHC vs PHG vs RYLPF Comparison Chart in %
loading
loading
loading
View a ticker or compare two or three

Which Stock Would AI Choose? GE HealthCare Technologies Inc. (GEHC) vs. Koninklijke Philips N.V. (PHG) vs. Koninklijke Philips N.V. (RYLPF) Stock Comparison

Key Takeaways

  • GEHC delivered strong year-to-date gains of approximately 25%, but experienced sharp volatility in recent weeks following a first-quarter earnings report and guidance adjustment.
  • PHG, the NYSE ADR for Koninklijke Philips N.V., showed modest year-to-date performance around 3-6%, with recent product launches supporting stability amid broader sector pressures.
  • RYLPF, the OTC listing of Koninklijke Philips N.V., mirrored PHG with similar year-to-date returns of about 5%, reflecting lower liquidity in over-the-counter trading.
  • All three stocks operate in the healthcare technology sector, focusing on imaging and diagnostics, but GEHC trades at a lower price-to-earnings (P/E) ratio compared to PHG.
  • Analyst targets suggest significant upside potential for GEHC at over 30%, while Philips listings face upcoming quarterly earnings that could influence sentiment.
  • Recent market activity highlights contrasts in momentum, with GEHC showing recovery potential post-pullback versus the steadier positioning of Philips tickers.

Introduction

This stock comparison examines GEHC, PHG, and RYLPF, all key players in healthcare technology, particularly medical imaging and diagnostics. Investors and traders interested in medtech sector exposure, relative performance amid economic pressures like inflation and supply chain issues, or valuation opportunities will find value here. With shared focus on innovation-driven growth, these tickers offer insights into U.S.-listed pure-play versus international diversified options, aiding decisions on momentum, stability, and risk in the current market environment.

GEHC Overview and Recent Performance

GE HealthCare Technologies Inc. (GEHC) is a leading provider of medical imaging, ultrasound, patient monitoring, and pharmaceutical diagnostics solutions, spun off from General Electric in 2023. Trading around $61 per share with a market capitalization of about $28 billion, it operates in a competitive landscape emphasizing AI-enhanced devices. In recent market activity, the stock declined sharply—over 13% in late April—following first-quarter results showing 2.9% organic revenue growth to $5.13 billion but pressured by inflation, tariffs, and a supplier issue. Management cut full-year adjusted EPS (earnings per share) guidance to $4.80-$5.00 from $4.95-$5.15, citing $250 million in added costs. Sentiment has shifted cautiously, though a record backlog and insider buying signal underlying strength, with analysts maintaining buy ratings and targets near $81.

PHG Overview and Recent Performance

Koninklijke Philips N.V. (PHG), via its NYSE ADR, delivers health technology across diagnosis, treatment, and informatics, with strengths in imaging, patient monitoring, and connected care. Priced near $26 with a $24 billion market cap equivalent, it benefits from a global footprint. Recent weeks saw modest declines, aligning with year-to-date returns of around 3-6%, amid anticipation for first-quarter earnings due early May. Positive developments include FDA clearances for the Spectral CT Verida and Bridge Plus Occlusion Balloon, bolstering procedural efficiency in CT imaging and lead extractions. These innovations have helped stabilize sentiment despite sector headwinds like tariff risks and European market softness, maintaining a higher P/E ratio reflective of growth expectations.

RYLPF Overview and Recent Performance

Koninklijke Philips N.V. (RYLPF) represents the ordinary shares traded over-the-counter, offering direct exposure to the Dutch parent company focused on healthcare innovation in imaging, ultrasound, and enterprise informatics. At roughly $25-28 per share, it tracks the underlying EUR-denominated performance with lower U.S. liquidity compared to PHG. Recent performance mirrors Philips' trajectory, with about 5% year-to-date gains and slight monthly upticks around 5%, buoyed by the same product advancements like Rembra platform expansions. Trading volume remains thin, amplifying sensitivity to parent news, while broader sentiment benefits from operational resilience amid macroeconomic challenges.

Trending AI Robots

Tickeron’s Trending AI Robots page showcases 25 top-performing AI trading bots selected from over 350 total bots that trade thousands of tickers across stocks, ETFs, and crypto. Curated for current market conditions, these bots employ diverse strategies—from momentum and sector rotation to pattern recognition—delivering annualized returns ranging from 23% to 163% and win rates of 51% to 88%. Examples include high performers in semiconductors (e.g., NVDA, AMD) and leveraged ETFs with up to 88% success rates. Tailored for varying timeframes and risk profiles, they provide real-time signals with built-in risk management. Traders can explore these elite performers to enhance strategies in volatile environments; visit Trending AI Robots for details.

Head-to-Head Comparison

GEHC emphasizes U.S.-centric imaging and diagnostics with a lower P/E (around 16) versus PHG and RYLPF (P/E near 27), suggesting better near-term value sensitivity but higher earnings volatility. Growth drivers differ: GEHC leverages a massive backlog and AI tools, while Philips tickers draw from diversified informatics and procedural devices, exposing them to Europe/China risks. Recent momentum favors Philips' steadiness post-product launches over GEHC's post-earnings dip, though GEHC's YTD outperformance highlights resilience. Risk factors include supply chains for all, with OTC RYLPF facing liquidity premiums versus liquid PHG. Sector exposure is concentrated in medtech, but GEHC shows superior analyst upside amid valuation trade-offs.

Tickeron AI Verdict

Tickeron’s AI models would likely favor GEHC in the current environment, given its trend consistency pre-pullback, substantial analyst price targets implying 30%+ upside, and strong year-to-date positioning despite recent catalysts like guidance cuts. Philips listings (PHG, RYLPF) offer stability via innovations but lag in relative momentum and valuation appeal, with probabilities tilting toward GEHC for short-to-medium-term outperformance based on observable backlogs and recovery signals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Interact to see
Advertisement
COMPARISON
Comparison
May 17, 2026
Stock price -- (GEHC: $60.76PHG: $25.23RYLPF: $25.50)
Brand notoriety: GEHC, PHG and RYLPF are all not notable
The three companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GEHC: 100%, PHG: 109%, RYLPF: 107%
Market capitalization -- GEHC: $27.64B, PHG: $24.6B, RYLPF: $25.66B
$GEHC is valued at $27.64B, while PHG has a market capitalization of $24.6B, and RYLPF's market capitalization is $25.66B. The market cap for tickers in this @Medical/Nursing Services ranges from $147.13B to $0. The average market capitalization across the @Medical/Nursing Services industry is $4.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GEHC’s FA Score shows that 0 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s), and RYLPF’s FA Score reflects 1 green FA rating(s).

  • GEHC’s FA Score: 0 green, 5 red.
  • PHG’s FA Score: 1 green, 4 red.
  • RYLPF’s FA Score: 1 green, 4 red.
According to our system of comparison, GEHC is a better buy in the long-term than PHG and RYLPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GEHC’s TA Score shows that 5 TA indicator(s) are bullish while PHG’s TA Score has 6 bullish TA indicator(s), and RYLPF’s TA Score reflects 4 bullish TA indicator(s).

  • GEHC’s TA Score: 5 bullish, 3 bearish.
  • PHG’s TA Score: 6 bullish, 3 bearish.
  • RYLPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHG is a better buy in the short-term than GEHC, which in turn is a better option than RYLPF.

Price Growth

GEHC (@Medical/Nursing Services) experienced а -4.27% price change this week, while PHG (@Medical/Nursing Services) price change was -3.66% , and RYLPF (@Medical/Nursing Services) price fluctuated -5.30% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.53%. For the same industry, the average monthly price growth was -5.85%, and the average quarterly price growth was -5.88%.

Reported Earning Dates

PHG is expected to report earnings on Jul 28, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.53% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GEHC($27.6B) has a higher market cap than RYLPF($25.7B) and PHG($24.6B). RYLPF has higher P/E ratio than PHG and GEHC: RYLPF (22.88) vs PHG (21.54) and GEHC (14.57). RYLPF and PHG YTD gains are higher at: -3.152 and -3.201 vs. GEHC (-25.855). GEHC has higher annual earnings (EBITDA): 3.6B vs. PHG (2.68B) and RYLPF (2.68B). GEHC has higher revenues than PHG and RYLPF: GEHC (21B) vs PHG (17.6B) and RYLPF (17.6B).
GEHCPHGRYLPF
Capitalization27.6B24.6B25.7B
EBITDA3.6B2.68B2.68B
Gain YTD-25.855-3.201-3.152
P/E Ratio14.5721.5422.88
Revenue21B17.6B17.6B
Total Cash2.26BN/A2.59B
Total Debt10.6BN/A8.1B
FUNDAMENTALS RATINGS
PHG vs RYLPF: Fundamental Ratings
PHG
RYLPF
OUTLOOK RATING
1..100
419
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7676
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
9999
SEASONALITY SCORE
1..100
3225

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHG's Valuation (3) in the Electronic Production Equipment industry is in the same range as RYLPF (5) in the null industry. This means that PHG’s stock grew similarly to RYLPF’s over the last 12 months.

PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as RYLPF (100) in the null industry. This means that PHG’s stock grew similarly to RYLPF’s over the last 12 months.

PHG's SMR Rating (76) in the Electronic Production Equipment industry is in the same range as RYLPF (76) in the null industry. This means that PHG’s stock grew similarly to RYLPF’s over the last 12 months.

PHG's Price Growth Rating (62) in the Electronic Production Equipment industry is in the same range as RYLPF (63) in the null industry. This means that PHG’s stock grew similarly to RYLPF’s over the last 12 months.

PHG's P/E Growth Rating (99) in the Electronic Production Equipment industry is in the same range as RYLPF (99) in the null industry. This means that PHG’s stock grew similarly to RYLPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GEHCPHGRYLPF
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
49%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
49%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 11 days ago
70%
Bullish Trend 11 days ago
62%
Bullish Trend 10 days ago
45%
Declines
ODDS (%)
Bearish Trend 18 days ago
59%
Bearish Trend 2 days ago
65%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 6 days ago
50%
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
GEHC
Daily Signal:
Gain/Loss:
PHG
Daily Signal:
Gain/Loss:
RYLPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VDI35.25N/A
N/A
Virtus International Dividend ETF
XHYE39.10-0.09
-0.22%
BondBloxx US High Yield Energy Sctr ETF
FSMB19.94-0.05
-0.23%
First Trust Short Dur Mgd Muncpl ETF
AIEQ48.84-0.58
-1.18%
Amplify AI Powered Equity ETF
BBCA98.53-1.29
-1.30%
JPMorgan BetaBuilders Canada ETF

GEHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEHC has been loosely correlated with CPAY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GEHC jumps, then CPAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEHC
1D Price
Change %
GEHC100%
-3.05%
CPAY - GEHC
60%
Loosely correlated
-0.29%
EEFT - GEHC
57%
Loosely correlated
-2.29%
GEN - GEHC
56%
Loosely correlated
+1.16%
ROP - GEHC
54%
Loosely correlated
+0.93%
ALIT - GEHC
53%
Loosely correlated
-1.73%
More

PHG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHG
1D Price
Change %
PHG100%
-1.06%
RYLPF - PHG
56%
Loosely correlated
N/A
GEHC - PHG
52%
Loosely correlated
-3.05%
ALC - PHG
49%
Loosely correlated
-0.56%
CNMD - PHG
46%
Loosely correlated
-2.34%
ENOV - PHG
44%
Loosely correlated
-7.01%
More